U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07182903) titled 'Fatigue in MS: From Invisible to Measurable' on Sept. 03.
Brief Summary: Fatigue is one of the most common and burdensome symptoms of MS, but its precise cause remains unknown, and an effective treatment is lacking. Previous research has shown that the progression of MS is associated with a higher presence of a specific type of T-cell, the cytotoxic CD4+ T-cells, which play a role in the immune system.
The aim of this study is to investigate whether these cells can also be linked to fatigue in people with MS.
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Multiple Sclerosis
Recruitment Status: NOT_YET_RECRUITI...